Product NDC: | 68084-550 |
Proprietary Name: | Rivastigmine Tartrate |
Non Proprietary Name: | Rivastigmine Tartrate |
Active Ingredient(s): | 1.5 mg/1 & nbsp; Rivastigmine Tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68084-550 |
Labeler Name: | American Health Packaging |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077131 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120106 |
Package NDC: | 68084-550-01 |
Package Description: | 10 BLISTER PACK in 1 CARTON (68084-550-01) > 10 CAPSULE in 1 BLISTER PACK (68084-550-11) |
NDC Code | 68084-550-01 |
Proprietary Name | Rivastigmine Tartrate |
Package Description | 10 BLISTER PACK in 1 CARTON (68084-550-01) > 10 CAPSULE in 1 BLISTER PACK (68084-550-11) |
Product NDC | 68084-550 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Rivastigmine Tartrate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120106 |
Marketing Category Name | ANDA |
Labeler Name | American Health Packaging |
Substance Name | RIVASTIGMINE TARTRATE |
Strength Number | 1.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |